Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Kavallaris

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
Nature Reviews. Cancer|February 12, 2010
Microtubules and resistance to tubulin-binding agentsMaria Kavallaris
IUBMB Life|April 2, 2008
Microtubules: a dynamic target in cancer therapyEddy Pasquier, Maria Kavallaris
International Journal of Oncology|August 9, 2002
Microtubule alterations and resistance to tubulin-binding agents (review)Sima Drukman, Maria Kavallaris
Cancer Research|December 3, 2008
Tubulin-targeted drug action: functional significance of class ii and class IVb beta-tubulin in vinca alkaloid sensitivityPei Pei Gan, Maria Kavallaris
Cell Cycle (Georgetown, Tex.)|December 25, 2015
Gamma-actin is involved in regulating centrosome function and mitotic progression in cancer cellsSela T Po'uha, Maria Kavallaris
Current Opinion in Molecular Therapeutics|July 23, 2003
Drug resistance mechanisms in cancer cells: a proteomics perspectiveNicole M Verrills, Maria Kavallaris
The Medical Journal of Australia|June 9, 2005
Proteomics and disease: opportunities and challengesMaria Kavallaris, Glenn M Marshall
Nature Reviews. Clinical Oncology|June 10, 2010
Metronomic chemotherapy: new rationale for new directionsEddy Pasquier, Maria Kavallaris, Nicolas André
Frontiers in Pharmacology|October 16, 2019
Modeling the Distribution of Diprotic Basic Drugs in Liposomal Systems: Perspectives on Malaria NanotherapyErnest Moles, Maria Kavallaris, Xavier Fernàndez-Busquets
Cancer Research|October 3, 2007
Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancerPei Pei Gan, Eddy Pasquier, Maria Kavallaris
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
Nature Reviews. Cancer|February 12, 2010
Microtubules and resistance to tubulin-binding agentsMaria Kavallaris
IUBMB Life|April 2, 2008
Microtubules: a dynamic target in cancer therapyEddy Pasquier, Maria Kavallaris
International Journal of Oncology|August 9, 2002
Microtubule alterations and resistance to tubulin-binding agents (review)Sima Drukman, Maria Kavallaris
Cancer Research|December 3, 2008
Tubulin-targeted drug action: functional significance of class ii and class IVb beta-tubulin in vinca alkaloid sensitivityPei Pei Gan, Maria Kavallaris
Cell Cycle (Georgetown, Tex.)|December 25, 2015
Gamma-actin is involved in regulating centrosome function and mitotic progression in cancer cellsSela T Po'uha, Maria Kavallaris
Current Opinion in Molecular Therapeutics|July 23, 2003
Drug resistance mechanisms in cancer cells: a proteomics perspectiveNicole M Verrills, Maria Kavallaris
The Medical Journal of Australia|June 9, 2005
Proteomics and disease: opportunities and challengesMaria Kavallaris, Glenn M Marshall
Nature Reviews. Clinical Oncology|June 10, 2010
Metronomic chemotherapy: new rationale for new directionsEddy Pasquier, Maria Kavallaris, Nicolas André
Frontiers in Pharmacology|October 16, 2019
Modeling the Distribution of Diprotic Basic Drugs in Liposomal Systems: Perspectives on Malaria NanotherapyErnest Moles, Maria Kavallaris, Xavier Fernàndez-Busquets
Cancer Research|October 3, 2007
Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancerPei Pei Gan, Eddy Pasquier, Maria Kavallaris
Pageof 16